COST-EFFECTIVENESS OF THE CELL-BASED QUADRIVALENT VERSUS THE STANDARD EGG-BASED QUADRIVALENT INFLUENZA VACCINE IN GERMANY.

被引：0
|
作者：
Cai, R. [1 ]
Eichner, M. [2 ]
Schwehm, M. [3 ]
Rajaram, S. [4 ]
Joaquin, F. M. Q. [5 ]
Lamotte, M. [6 ]
机构：
[1] IQVIA, Amsterdam, Netherlands
[2] Univ Tubingen, Tubingen, Germany
[3] ExploSYS GmbH, Leinfelden Echterdingen, Germany
[4] Seqirus, Maidenhead, Berks, England
[5] Seqirus, Summit, NJ USA
[6] IQVIA, Zaventem, Belgium
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN32
引用
收藏
页码：S548 / S548
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population
    Marbaix, Sophie
    Dauby, Nicolas
    Mould-Quevedo, Joaquin
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 608 - 619
  • [32] Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis
    You, Joyce H. S.
    Ming, Wai-Kit
    Chan, Paul K. S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (03) : 564 - 571
  • [33] QUADRIVALENT INFLUENZA VACCINE IN HONG KONG- A COST-EFFECTIVENESS ANALYSIS
    You, J.
    Ming, W.
    Chan, P.
    VALUE IN HEALTH, 2014, 17 (07) : A678 - A678
  • [34] Effectiveness of Cell-Based Quadrivalent Seasonal Influenza Vaccine: A Systematic Review and Meta-Analysis
    Coleman, Brenda L.
    Gutmanis, Iris
    Mcgovern, Ian
    Haag, Mendel
    VACCINES, 2023, 11 (10)
  • [35] THE POTENTIAL COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INACTIVATED INFLUENZA VACCINE FOR THE PORTUGUESE ELDERLY POPULATION
    Tavares, D.
    Martin Saborido, C.
    Mourino, H.
    Anton Rodriguez, C.
    VALUE IN HEALTH, 2019, 22 : S651 - S652
  • [36] Differential Induction of Interferon-Stimulated Genes by Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Children During the 2018-2019 Season
    Martin, Judith M.
    Geffel, Krissy Moehling
    Ortiz, Marianna A.
    Rajasundaram, Dhivyaa
    Nowalk, Mary Patricia
    Zimmerman, Richard K.
    Alcorn, John F.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (05): : 1393 - 1401
  • [37] Determination of the potency of a cell-based seasonal quadrivalent influenza vaccine using a purified primary liquid standard
    Takahashi, Hitoshi
    Fujimoto, Takao
    Horikoshi, Fumiaki
    Uotani, Tae
    Okutani, Mie
    Shimasaki, Noriko
    Hamamoto, Itsuki
    Odagiri, Takato
    Nobusawa, Eri
    BIOLOGICALS, 2020, 68 : 32 - 39
  • [38] Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina
    Uruena, Analia
    Micone, Paula
    Cecilia Magneres, Maria
    McGovern, Ian
    Mould-Quevedo, Joaquin
    Rocha Sarmento, Tulio Tadeu
    Giglio, Norberto
    VACCINES, 2022, 10 (10)
  • [39] The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany
    Kohli, Michele A.
    Maschio, Michael
    Cartier, Shannon
    Mould-Quevedo, Joaquin
    Fricke, Frank-Ulrich
    VACCINES, 2022, 10 (09)
  • [40] Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons
    Boikos, Constantina
    McGovern, Ian
    Molrine, Deborah
    Ortiz, Justin R.
    Puig-Barbera, Joan
    Haag, Mendel
    VACCINES, 2022, 10 (06)
12345